Search

Learn everything you need to know about donating bone marrow or blood stem cells and why it’s important to join a public registry.

… Thursday, July 25, 2024 Imagine finding out that your bone marrow or blood stem cells could save the life of someone who needed it — even a complete stranger. Memorial Sloan Kettering Cancer Center (MSK) nurse Grace Yang, RN, received such a call in March 2024.   “This is definitely something I was never

Using patients’ own immune systems to fight cancer has been one of the most exciting advances in cancer treatment over the past decade. Now, a new immunotherapy could take this approach to the next level.

… Thursday, July 1, 2021 Using patients’ own immune systems to fight cancer has been one of the most exciting advances in cancer treatment over the past decade. Now, a new immunotherapy could take this approach to the next level. The treatment, called tumor infiltrating lymphocyte (TIL) therapy, harnesses

The incidence of colorectal cancer in those under the age of 50 has been increasing globally at an alarming rate. Pinpointing the reason remains elusive. Memorial Sloan Kettering has just opened the first center in the world dedicated to research and treatment of the disease as it presents in this demographic.

… Thursday, March 15, 2018 We are excited to announce the opening of the Center for Young Onset Colorectal Cancer at Memorial Sloan Kettering Cancer Center. This is the first center in the world dedicated to adults under the age of 50 with colorectal cancer. Its two-part mission is to: provide coordinated

MSK researchers recently reported results of a phase 2 trial for GIST, a rare form of gastrointestinal cancer. The trial was based on years of lab work conducted by physician-scientist Ping Chi.

… Friday, February 11, 2022 When Luis Portiansky had his first surgery in 1993 for a rare form of cancer that developed in his stomach, Ping Chi was still an undergraduate student at Mount Holyoke College in Massachusetts. More than two decades later, when Luis’ cancer came back for the third time, Dr.

MSK was recently in the news regarding our relationship with a technology spin-off company called Paige.AI.

… Sunday, September 23, 2018 MSK was recently in the news regarding our relationship with a technology spin-off company called Paige.AI. The MSK board and leadership believe that this pioneering work has the potential to improve the diagnosis and care of cancer patients around the world. MSK is proud to

MSK achieved status as a Magnet®-recognized organization, an esteemed honor for nursing excellence.

… Wednesday, February 17, 2016 Summary The American Nurses Credentialing Center granted Magnet recognition ® to MSK today, a prestigious honor given to institutions that demonstrate nursing excellence. This achievement confirms the superb performance of the entire nursing staff and marks the culmination

Find out how to handle feelings of self-blame and shame that may accompany a cancer diagnosis.

… Wednesday, October 9, 2019 Summary Many people experience self-blame around a cancer diagnosis, and some may even experience feelings of embarrassment or shame. There are ways around that, says MSK social worker Kristie Redfield. Having cancer is difficult. Adding feelings of guilt, shame, or embarrassment

Worry and confusion around COVID-19 are common in the general population, but cancer patients are also balancing concern over what the pandemic means for their treatment, prognosis, and vulnerability to the virus.

… Tuesday, May 5, 2020 Worry and confusion around COVID-19 are common in the general population, but cancer patients are also balancing concern over what the pandemic means for their treatment, prognosis, and vulnerability to the virus. Doctors and nurses at Memorial Sloan Kettering (MSK) shared their

A study by Memorial Sloan Kettering (MSK) recently published in JAMA Oncology showed that radiation dose to the elective regions can be safely de-escalated for patients with human papillomavirus (HPV)-associated oropharyngeal cancer (OPC) who received concurrent chemotherapy.

… Thursday, March 10, 2022 A study by Memorial Sloan Kettering (MSK) recently published in JAMA Oncology   (1) showed that radiation dose to the elective regions can be safely de-escalated for patients with human papillomavirus (HPV)-associated oropharyngeal cancer (OPC) who received concurrent chemotherapy

Leaders from both institutions announced their collaboration and shared details about what it can mean for people with cancer in the state and throughout the world.

… Wednesday, December 14, 2016 Executives at Memorial Sloan Kettering and Hackensack Meridian Health announce a partnership at a press conference Dr. Sergio Giralt (left), Chief of Memorial Sloan Kettering's Adult Bone Marrow Transplant Service and Melvin Berlin Family Chair in Multiple Myeloma, and Dr